Artificial intelligence is moving beyond general-purpose applications as companies develop specialized tools for industries with complex operational and regulatory requirements. In life sciences, where communicating clinical evidence requires accuracy, consistency, and technical knowledge, this shift is creating opportunities for technology companies building AI solutions for specialized workflows.
Prezent Vivo, the life sciences-focused offering from Prezent, has been recognized at the sixth annual BioTech Breakthrough Awards, an industry program highlighting companies and technologies advancing biotechnology and related markets.
Founded by Rajat Mishra, Prezent develops AI-powered business communication solutions. Through Prezent Vivo, the company targets pharmaceutical, biotechnology, and other life sciences organizations that need to translate complex scientific information into clear, accurate, and audience-specific communications.
The BioTech Breakthrough Awards are organized by BioTech Breakthrough, part of the Tech Breakthrough market intelligence and recognition organization. The annual program recognizes innovation across biotechnology, including biopharmaceuticals, therapeutics, genomics, medical technology, data analytics, and artificial intelligence.
Submissions are evaluated by an independent panel of industry experts, who consider factors such as innovation, functionality, performance, market impact, and value. For technology companies operating in specialized markets, the recognition offers industry visibility and an opportunity to demonstrate the relevance of their solutions to evolving sector requirements.
Applying specialized AI to life sciences
Prezent Vivo focuses on a challenge that extends across pharmaceutical and biotechnology organizations: communicating scientific and clinical information to different stakeholders without compromising accuracy or regulatory requirements.
Its capabilities include the development of scientific posters, data visualizations, medical documents, brochures, Medical Science Liaison (MSL) materials, advisory board content, and commercial communications.
A central component of the platform is Astrid, an AI agent developed specifically for life sciences communication. According to Prezent, the system incorporates considerations such as regulatory language, clinical evidence structures, brand guidelines, and medical and commercial strategies.
The company also combines AI-driven processes with human expertise, including medical writers and communication specialists who provide editorial oversight and scientific judgment. This model addresses a key challenge in enterprise AI adoption: general-purpose systems can accelerate content generation, but specialized industries require additional controls to ensure that outputs meet technical and regulatory expectations.
Prezent Vivo offers different engagement models, including a self-service AI environment, overnight communication services, and fixed-price projects for more complex requirements.
The recognition comes amid a broader shift toward industry-specific AI applications. While general-purpose models have expanded access to automated content generation and data processing, companies in regulated sectors are increasingly exploring specialized systems that incorporate domain knowledge into their workflows.
In life sciences, this creates opportunities beyond research and drug discovery. Pharmaceutical companies also need to manage the communication of clinical findings, coordinate medical and commercial teams, and ensure that scientific information remains consistent across different channels and audiences.
Prezent reports that more than 150 life sciences companies use its solutions, including 45 of the world’s top 50 biopharmaceutical organizations. These figures reflect the company’s reported customer base and its focus on serving enterprise requirements in the sector.
For Prezent, the recognition of Prezent Vivo at the BioTech Breakthrough Awards adds an industry distinction to its expansion into specialized life sciences applications.
More broadly, the development highlights how AI companies are moving toward vertical solutions that combine automation, industry-specific knowledge, and human oversight. In sectors where accuracy and regulatory compliance are essential, the ability to adapt AI to the requirements of a particular industry may become an important factor in enterprise adoption.